Gene · 4973
Papers4,129
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 4,129
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel diagnostic biomarkers of oxidative stress, immunological characterization and experimental validation in Alzheimer's disease. | Aging (Albany NY) | 2023 | 37801482 | PubTator, text mining | PubMed |
| Bridging the gap between clear cell renal cell carcinoma and cutaneous melanoma: the role of SCARB1 in dysregulated cholesterol metabolism. | Aging (Albany NY) | 2023 | 37801479 | PubTator, text mining | PubMed |
| Progresses in biomarkers for cancer immunotherapy. | MedComm (2020) | 2023 | 37799808 | PubTator, text mining | PubMed |
| Neuregulin-1β Improves Uremic Cardiomyopathy and Renal Dysfunction in Rats. | JACC Basic Transl Sci | 2023 | 37791301 | PubTator, text mining | PubMed |
| The functional response of human monocyte-derived macrophages to serum amyloid A and Mycobacterium tuberculosis infection. | Front Immunol | 2023 | 37781389 | PubTator, text mining | PubMed |
| LDL binding to cell receptors and extracellular matrix is proatherogenic in obesity but improves after bariatric surgery. | J Lipid Res | 2023 | 37777014 | PubTator, text mining | PubMed |
| The Anti-Thrombotic Effects of PCSK9 Inhibitors. | Pharmaceuticals (Basel) | 2023 | 37765005 | PubTator, text mining | PubMed |
| Targeting Collagen Pathways as an HFpEF Therapeutic Strategy. | J Clin Med | 2023 | 37762803 | PubTator, text mining | PubMed |
| Novel Therapeutic Approaches to Prevent Atherothrombotic Ischemic Stroke in Patients with Carotid Atherosclerosis. | Int J Mol Sci | 2023 | 37762627 | PubTator, text mining | PubMed |
| Postprandial Hyperlipidemia: Its Pathophysiology, Diagnosis, Atherogenesis, and Treatments. | Int J Mol Sci | 2023 | 37762244 | PubTator, text mining | PubMed |
| A Multiplexed Urinary Biomarker Panel Has Potential for Alzheimer's Disease Diagnosis Using Targeted Proteomics and Machine Learning. | Int J Mol Sci | 2023 | 37762058 | PubTator, text mining | PubMed |
| Circular RNA circARPC1B functions as a stabilisation enhancer of Vimentin to prevent high cholesterol-induced articular cartilage degeneration. | Clin Transl Med | 2023 | 37740460 | PubTator, text mining | PubMed |
| Maternal PlGF and umbilical Dopplers predict pregnancy outcomes at diagnosis of early-onset fetal growth restriction. | J Clin Invest | 2023 | 37712421 | PubTator, text mining | PubMed |
| Association of oxidized ApoB and oxidized ApoA-I with high-risk coronary plaque features in cardiovascular disease. | JCI Insight | 2023 | 37698922 | PubTator, text mining | PubMed |
| SPP1/osteopontin: a driver of fibrosis and inflammation in degenerative ascending aortic aneurysm? | J Mol Med (Berl) | 2023 | 37698712 | PubTator, text mining | PubMed |
| Study of LncRNA BANCR Expression in Tumor Tissues and Adjacent Normal Tissues in Gastric Cancer Patients. | Adv Biomed Res | 2023 | 37694252 | PubTator, text mining | PubMed |
| Potential Predictive Biomarkers of Systemic Drug Therapy for Hepatocellular Carcinoma: Anticipated Usefulness in Clinical Practice. | Cancers (Basel) | 2023 | 37686621 | PubTator, text mining | PubMed |
| Mutational Landscape and Precision Medicine in Hepatocellular Carcinoma. | Cancers (Basel) | 2023 | 37686496 | PubTator, text mining | PubMed |
| Effect of Repeated Bolus and Continuous Glucose Infusion on DNA Damage and Oxidative Stress Biomarkers in Healthy Male Volunteers. | Int J Mol Sci | 2023 | 37686414 | PubTator, text mining | PubMed |
| The Role of Biomarkers, Metabolomics, and COVID-19 in Venous Thromboembolism-A Review of Literature. | Int J Mol Sci | 2023 | 37686216 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4973/papers?page=20